Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of nalbuphine injection for analgesia in mechanically ventilated ICU patients
CTR20232304Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Oct 2023; status: completed.
02
Drugs
nalbuphine
03
Conditions
pain
Beyond the preview
Go deeper on CTR20232304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232304.